Items where Author is "Visser, L."

2021

Guery, R. and Walker, S. L. and Harms, G. and Neumayr, A. and Van Thiel, P. and Gangneux, J. P. and Clerinx, J. and Söbirk, S. K. and Visser, L. and Lachaud, L. and Bailey, M. and Bart, A. and Ravel, C. and Van der Auwera, G. and Blum, J. and Lockwood, D. N. and Buffet, P. and LeishMan Network, and the French Cutaneous Leishmaniasis Study group, . (2021) Clinical diversity and treatment results in tegumentary leishmaniasis: a European clinical report in 459 patients. PLoS Negl Trop Dis, 15 (10). e0009863.

2015

Schlagenhauf, P. and Hatz, C. and Behrens, R. and Visser, L. and Funk, M. and Holzer, B. and Beck, B. and Bourquin, C. and Etter, H. and Furrer, H. and Genton, B. and Landry, P. and Chappuis, F. and Loutan, L. and Stossel, U. and Jeschko, E. and Rossano, A. and Nothdurft, H. D.. (2015) Mefloquine at the crossroads? : Implications for malaria prophylaxis in Europa. Travel medicine and infectious disease, Vol. 13, H. 2. pp. 192-196.

2012

Blum, J. and Lockwood, D. N. J. and Visser, L. and Harms, G. and Bailey, M. S. and Caumes, E. and Clerinx, J. and van Thiel, Ppam and Morizot, G. and Hatz, C. and Buffet, P.. (2012) Local or systematic treatment for New World cutaneous leishmaniasis? : Re-evaluating the evidence for the risk of mucosal leishmaniasis. International health, Vol. 4, H. 3. pp. 153-163.

1998

Laman, J. D. and Maassen, C. B. and Schellekens, M. M. and Visser, L. and Kap, M. and de Jong, E. and van Puijenbroek, M. and van Stipdonk, M. J. and van Meurs, M. and Schwärzler, C. and Günthert, U.. (1998) Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide. Multiple sclerosis, Vol. 4, no. 3. pp. 147-153.